Codexis (CDXS) Net Equity Issued and Repurchased (2010 - 2025)
Codexis (CDXS) posted quarterly Net Equity Issued and Repurchased of -$1000.0 for Q4 2025, little changed year-over-year from -$1000.0 in Q4 2024, and little changed quarter-over-quarter from -$1000.0 in Q4 2024.
Codexis (CDXS) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
Codexis' Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at -$1000.0 for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed 0.0% year-over-year to -$1000.0; the TTM figure through Dec 2025 stood at $31.3 million (changed 0.0% YoY), while the FY2025 annual figure was $17.3 million, down 44.87% from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at -$1000.0, roughly flat from -$1000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $31.3 million in Q3 2024, with the low at -$1000.0 in Q4 2024.
- The 3-year median for Net Equity Issued and Repurchased is $1.5 million (2023), against an average of $8.0 million.
- Peak annual rise in Net Equity Issued and Repurchased reached 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
- Codexis' Net Equity Issued and Repurchased stood at $7.1 million in 2023, then sank by 100.01% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025.
- Business Quant data shows CDXS's Net Equity Issued and Repurchased at -$1000.0 in Q4 2025, -$1000.0 in Q4 2024, and $31.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 31.32 Mn |
| Sep 30, 2024 | 31.32 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2019 | -50.00 Mn |
| Dec 31, 2019 | -50.00 Mn |
| Jun 30, 2019 | 49.90 Mn |
| Jun 30, 2019 | 49.90 Mn |
| Dec 31, 2018 | 37.50 Mn |
| Dec 31, 2018 | 37.50 Mn |
| Dec 31, 2017 | 553,000.00 |
| Dec 31, 2017 | 553,000.00 |
| Sep 30, 2017 | -62,000.00 |
| Sep 30, 2017 | -62,000.00 |